This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Infantile Sialic Acid Storage Disease
Information about Infantile Sialic Acid Storage Disease: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Infantile Sialic Acid Storage Disease
Most recent studies have shown that Infantile Sialic Acid Storage Disease shares some biological mechanisms with ataxia, atrophy, fetal-diseases, hypertrophy, hypoplasia, inborn-errors-of-metabolism, lysosomal-storage-diseases, metabolic-diseases, nephrosis, nervousness, neurodegenerative-disorders, sialic-acid-storage-disease-finnish-type-(disorder), sialuria, storage-disease.
Among the many pathways, these few ones have gauged particular interests from scientists studying Infantile Sialic Acid Storage Disease, and have been seen in publications frequently: Amino Acid Transport, Endocytosis, Excretion, Intracellular Transport, Localization, Lysosomal Transport, Monosaccharide Transport, Myelination, Oligodendrocyte Development, Pathogenesis, Secretion, Sialic Acid Transport, Symport, Transport, Visual Perception
Quite a number of genes have been found to play important roles in Infantile Sialic Acid Storage Disease, such as BRD2, CDCA3, CMA1, CTNS, ITGA2, KIAA1109, MBL2, MBP, MCTS1, PRG2, SLC16A1, SLC16A3, SLC16A7, SLC16A8, SLC17A5. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.